Irrespective of a direct role of DCX in NB cell motility, the present data suggest that the detection of DCX+ cells in untreated and treated tumors in neuroblastoma affected patients may be prognostic of tumor aggressiveness, as well as of a severe tumor relapse after treatment. Here, DCX is linked to neuroblastoma.